|
Volumn 20, Issue 2, 1993, Pages 303-321
|
Cytotoxic chemotherapy for advanced renal cell carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMETANTRONE;
BISANTRENE;
CIMETIDINE;
COUMARIN;
CYTOTOXIC AGENT;
DIDEMNIN B;
ELLIPTINIUM;
FLOXURIDINE;
FLUOROURACIL;
GEMCITABINE;
INTERFERON;
LONIDAMINE;
MEDROXYPROGESTERONE;
METHOTREXATE;
MITOXANTRONE;
PACLITAXEL;
PIRARUBICIN;
SPARFOSIC ACID;
TAMOXIFEN;
TIOGUANINE;
UNINDEXED DRUG;
VINBLASTINE SULFATE;
ADVANCED CANCER;
BOLUS INJECTION;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
DRUG FATALITY;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY CARCINOMA;
MAJOR CLINICAL STUDY;
MULTIDRUG RESISTANCE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
SEPSIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
COMBINED MODALITY THERAPY;
HUMAN;
KIDNEY NEOPLASMS;
|
EID: 0027273479
PISSN: 00940143
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (178)
|
References (0)
|